ARS Pharmaceuticals, Inc.
SPRY· Nasdaq
ARS Pharmaceuticals, Inc.
- Last sale
- Oct 1, 2026 · -4.64%
- Market cap
- $408.73M
- 99.45M shares
- Filings
- 542
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $84,278,000 | reported | |
| FY 2024 | 2024-12-31 | $89,149,000 | reported | |
| FY 2023 | 2023-12-31 | $30,000 | reported | |
| FY 2022 | 2022-12-31 | $1,316,000 | reported | |
| FY 2021 | 2021-12-31 | $5,506,000 | reported |
ARS Pharmaceuticals, Inc. · CIK 1671858 · Engraved from SEC EDGAR
